My friend's father was diagnosed with Alzheimer's disease after showing signs of memory loss and mental fogginess. His symptoms began with forgetting recent events and family stories but progressed to forgetting his grandchildren's names and needing full-time supervision. This progression is consistent with damage first to the hippocampus and then spreading to other brain regions like the neocortex as the disease advances. The pathological features of Alzheimer's disease include amyloid plaques and neurofibrillary tangles composed of tau proteins that begin in certain brain areas and spread to others over the course of the disease, correlated with cognitive decline. Synaptic loss driven by amyloid and tau is also thought to underlie memory and cognitive symptoms in the early stages of Alzheimer's disease.
Alzheimer's disease is a progressive disorder that causes brain cells to waste away (degenerate) and die. Alzheimer's disease is the most common cause of dementia — a continuous decline in thinking, behavioral and social skills that disrupts a person's ability to function independently.
Symptoms: Amnesia; Dementia
Diseases or conditions caused: Dementia
Pathophysiology
Pathology
BPharm 2nd Semester
MPharm
Therapeutics
MBBS
Alzheimer's disease is a progressive disorder that causes brain cells to waste away (degenerate) and die. Alzheimer's disease is the most common cause of dementia — a continuous decline in thinking, behavioral and social skills that disrupts a person's ability to function independently.
Symptoms: Amnesia; Dementia
Diseases or conditions caused: Dementia
Pathophysiology
Pathology
BPharm 2nd Semester
MPharm
Therapeutics
MBBS
A presentation about Alzheimer's disease, it's definition, it's etiology, its mechanism of development as well as actual treatment and developing treatments.
Alzheimer's disease is a causes a progressive loss of brain cells leading to memory loss. In this slide we will learn about its causes,symptoms, pathophysiology, treatment, medication and risk factors.
Complete pathophysiology of Alzheimer Disease for B.Pharm and D.Pharm Students and also for medical students.
Definition, Etiology, Pathogenesis, Clinical Manifestations, Diagnosis, Pharmacological and Non Pharmacological Treatments.
D.Pharm Students, B.Pharm Students, Pharmacoogy and Medical Students.
Alzheimer's disease is a progressive neurologic disorder that causes atrophy of brain cells, leading it to cell death. it is degenerative and progressive illness. Increase in age with sedentary lifestyle and lack of brain storming activities are indirectly leading to mental disorders with cognitive disruptions like dementia and lading up into Alzheimer's, which makes life miserable of client due to dependency. It is essential to keep the elderly active physiologically as well as psychologically. Statistical data of several studies shows the rise in the cases of Alzheimer's disease, which is the highlighting point of concern. Due to increased digitalization and decreased socialization among the human species throughout globe is leading to increased in risk of getting cognitive deficits.
Alzheimer's disease is a degenerative
brain disorder of unknown etiology which
is the most common form of dementia, that
usually starts in late middle age or in old
age, results in progressive memory loss,
impaired thinking, disorientation, and
changes in personality and mood. There is
degeneration of brain neurons especially in
the cerebral cortex and presence of
neurofibrillary tangles and plaques
containing beta-amyloid cells
The disease was first described
by Dr. Alois Alzheimer, a German
physician, in 1906. Alzheimer had a
patient named Auguste D, in her
fifties who suffered from what
seemed to be a mental illness. But
when she died in 1906, an autopsy
revealed dense deposits, now called
neuritic plaques, outside and around
the nerve cells in her brain. Inside
the cells were twisted strands of
fiber, or neurofibrillary tangles.
Since Dr. Alois Alzheimer's was the
first person who discovered the
disease, AD was named after him.
the feathers of the disease and It is histology
For downloading the presentation, more presentations , infographics and blogs visit :
studyscienceblog.wordpress.com
A presentation about Alzheimer's disease, it's definition, it's etiology, its mechanism of development as well as actual treatment and developing treatments.
Alzheimer's disease is a causes a progressive loss of brain cells leading to memory loss. In this slide we will learn about its causes,symptoms, pathophysiology, treatment, medication and risk factors.
Complete pathophysiology of Alzheimer Disease for B.Pharm and D.Pharm Students and also for medical students.
Definition, Etiology, Pathogenesis, Clinical Manifestations, Diagnosis, Pharmacological and Non Pharmacological Treatments.
D.Pharm Students, B.Pharm Students, Pharmacoogy and Medical Students.
Alzheimer's disease is a progressive neurologic disorder that causes atrophy of brain cells, leading it to cell death. it is degenerative and progressive illness. Increase in age with sedentary lifestyle and lack of brain storming activities are indirectly leading to mental disorders with cognitive disruptions like dementia and lading up into Alzheimer's, which makes life miserable of client due to dependency. It is essential to keep the elderly active physiologically as well as psychologically. Statistical data of several studies shows the rise in the cases of Alzheimer's disease, which is the highlighting point of concern. Due to increased digitalization and decreased socialization among the human species throughout globe is leading to increased in risk of getting cognitive deficits.
Alzheimer's disease is a degenerative
brain disorder of unknown etiology which
is the most common form of dementia, that
usually starts in late middle age or in old
age, results in progressive memory loss,
impaired thinking, disorientation, and
changes in personality and mood. There is
degeneration of brain neurons especially in
the cerebral cortex and presence of
neurofibrillary tangles and plaques
containing beta-amyloid cells
The disease was first described
by Dr. Alois Alzheimer, a German
physician, in 1906. Alzheimer had a
patient named Auguste D, in her
fifties who suffered from what
seemed to be a mental illness. But
when she died in 1906, an autopsy
revealed dense deposits, now called
neuritic plaques, outside and around
the nerve cells in her brain. Inside
the cells were twisted strands of
fiber, or neurofibrillary tangles.
Since Dr. Alois Alzheimer's was the
first person who discovered the
disease, AD was named after him.
the feathers of the disease and It is histology
For downloading the presentation, more presentations , infographics and blogs visit :
studyscienceblog.wordpress.com
Introduction to AI for Nonprofits with Tapp NetworkTechSoup
Dive into the world of AI! Experts Jon Hill and Tareq Monaur will guide you through AI's role in enhancing nonprofit websites and basic marketing strategies, making it easy to understand and apply.
Safalta Digital marketing institute in Noida, provide complete applications that encompass a huge range of virtual advertising and marketing additives, which includes search engine optimization, virtual communication advertising, pay-per-click on marketing, content material advertising, internet analytics, and greater. These university courses are designed for students who possess a comprehensive understanding of virtual marketing strategies and attributes.Safalta Digital Marketing Institute in Noida is a first choice for young individuals or students who are looking to start their careers in the field of digital advertising. The institute gives specialized courses designed and certification.
for beginners, providing thorough training in areas such as SEO, digital communication marketing, and PPC training in Noida. After finishing the program, students receive the certifications recognised by top different universitie, setting a strong foundation for a successful career in digital marketing.
Model Attribute Check Company Auto PropertyCeline George
In Odoo, the multi-company feature allows you to manage multiple companies within a single Odoo database instance. Each company can have its own configurations while still sharing common resources such as products, customers, and suppliers.
Read| The latest issue of The Challenger is here! We are thrilled to announce that our school paper has qualified for the NATIONAL SCHOOLS PRESS CONFERENCE (NSPC) 2024. Thank you for your unwavering support and trust. Dive into the stories that made us stand out!
A review of the growth of the Israel Genealogy Research Association Database Collection for the last 12 months. Our collection is now passed the 3 million mark and still growing. See which archives have contributed the most. See the different types of records we have, and which years have had records added. You can also see what we have for the future.
2. Table of content
• Alzheimer’s symptoms in my friend’s father
• Professor Mason’s lectures reference
• Potential Alzheimer’s Decease (AD) mechanisms
3. Alzheimer’s symptoms in my friend’s father
My friend's father has always been a very active and sharp individual.
During the last couple of years, he started showing signs of mental
"fogginess": it became difficult for him to concentrate on his favorite
grandson stories, he is asking the same questions repeatedly, he is
forgetting family events and he is routinely misplacing possessions.
Lately he started forgetting his grand children names and became
uncapable of staying home alone, even for a short while, due to his
unpredictable behavior that have resulted in injury and domestic
accidents.
He is moody and frustrated most of the time. His relations with
grandchildren deteriorated and my friend is in a constant warry for his
wellbeing.
He was diagnosed with Alzheimer.
4. Professor Mason’s lecture reference
As the prominent symptoms of the disease, especially in the early
stages, seem to be related to the gradually increasing inability to
remember recent events, it reminded me of Professor Mason’s lecture
on “Memory loss” and made me to suspect that the hippocampus is
being gradually damaged. As professor Mason explained, hippocampus
is critical for episodic and semantic memories creation, and episodic
memories access. This is aligned with the initial symptoms, but when he
started forgetting his grandchildren names, semantic memory from few
years ago, it made me think that in the later stages, there must be some
additional damage to the neocortex.
My friend’s father hasn’t reached this step yet, but other Alzheimer’s
patients gradually lost bodily functions, ultimately leading to death. This
indicates that their autonomous neural systems and motor cortex
could have been impaired as well.
5. Potential Alzheimer’s Decease (AD) mechanisms
Based on https://molecularneurodegeneration.biomedcentral.com/articles/10.1186/s13024-019-0333-5
Macroscopic examination of an AD brain confirms that there are anomalies in the frontal and temporal
(including hippocampus) cortices: They often have enlarged sulcal spaces with atrophy of the gyri.
There is also atrophy in precuneus, that is also involved in memory tasks, and posterior cingulate gyrus.
The AD brain often has at least moderate atrophy in multimodal association cortices, that is connected to
conceptual cognitive functions and planning motor actions. Decreased brain weight is observed in most
affected individuals.
The definitive diagnosis of AD requires microscopic examination, enabling to discover Amyloid plaques and
neurofibrillary tangles.
Amyloid plaques are mainly composed of beta-amyloid that are fragments of a larger protein. When these
fragments cluster together, they appear to have a toxic effect on neurons and to disrupt cell-to-cell
communication. Distribution of amyloid plaques: Basal frontal and temporal lobes are affected in Stage A,
extension into the association neocortices and hippocampus in Stage B, and finally reaching primary
cortices, subcortical nuclei and cerebellum in Stage C.
6. Potential Alzheimer’s Decease (AD) mechanisms
(continue)
In Alzheimer's disease, tau proteins change shape and organize themselves into structures called
neurofibrillary tangles (NFT). The mature tangles displace the nucleus and other vital cellular components,
and eventually the neurons die.
In Stage I neurons of the transentorhinal cortex are first to accumulate the NFTs along with the occasional
tangles in the hippocampus and selected nuclei in the basal forebrain and thalamus.
In Stage II NFTs observed in Stage I become more robust and the entorhinal cortex, the main interface
between the hippocampus and neocortex, becomes involved. In the first two stages NFTs are sparse in the
hippocampus proper and virtually absent in the neocortex.
In Stage III the transentorhinal and entorhinal cortices are fully involved. NFTs can also be observed in
subiculum. Tangles in the basal forebrain and the thalamus also become more pronounced.
In Stage IV NFTs corticomedial complex, the basolateral nuclei of the amygdala and some portions of the
putamen and accumbens nucleus become impacted. All previous pathology becomes more robust.
In Stage V there is extensive involvement of the neocortex.
In Stage VI previously affected areas continue to deteriorate and the primary motor cortex becomes impacted.
7. Potential Alzheimer’s Decease (AD) mechanisms
(continue)
Synaptic loss:
Cognitive decline and decreases in verbal fluency early in AD are believed to reflect the decreases in synaptic
density in the hippocampus and medial temporal lobes. Synaptic loss precedes neuronal loss, and these effects
are probably driven by amyloid and tau pathology.
Additional pathologic changes observed in AD patients, although their role is unclear:
Granulovacuolar degeneration: Abundance of 3–5 μm intraneuronal vacuoles with a central 0.5–1.5 μm dense
granule. Those vacuoles accumulate in the hippocampus first, followed by the entorhinal cortex and temporal
neocortex and finally the amygdala, thalamus, cingulate gyrus and even association cortices.
Hirano bodies: Higher presence of rod-like inclusions, most observed in the hippocampus
Inflammatory response: Microglial cells, operating within the brain as phagocytes, become activated and their
numbers increase in promotion to neuronal damage associated with NFTs. Reactive astrocytes represent the
other inflammatory response observed in the brains of AD patients.